-
Combination therapeutic regimen for treating breast cancer and inducing apoptosis in breast cancer cells, comprises resveratrol and/or a derivative as a deoxyribonucleic acid-damaging agent, and an olaparib and/or a derivative as a deoxyribonucleic acid repair inhibitor
2024-11-13
-
Carrying out biochemical assay for quantitatively determining efficacy of poly (ADP-ribose) polymerase inhibitor in cancer treatment, involves isolating cancer cells from cancer patients exposed or not exposed to combination treatment of DNA damaging agent and poly (ADP-ribose) polymerase inhibitor
2024-09-06
-
Synthesizing gold nanoparticles useful in biomedical applications by adding gold(III) chloride solution to deionized water, rapidly adding sodium citrate solution, boiling, preparing larger nanoparticles by using gold nanoparticles as seeds and mixing with gold(III) chloride and adding ascorbic acid
2024-09-06
-
Culturing and expanding human dental pulp stem cells used in regenerative medicine, tissue engineering, and dental research, involves washing pulp tissue in phosphate buffer saline and chopping it into pieces in a media containing antibiotics, and treating with collagenase and dispase in water bath
2024-07-31
-
Process of separating one of lead and zinc concentrate from smelter slag, involves draining slag directly from smelter and cooling naturally in air, grinding and sulfidizing cooled slag, and froth floating sulphidized slag to obtain lead and/or zinc concentrate
2023-09-05
-
Olaparib (AZD2281) a PARP inhibitor & curcumin synergistically induces apoptosis in oral cancer stem cells by inhibiting the DNA repair cascade
2018
